Rationale and design of the randomised, controlled Percutaneous coronary intervention using Assisted Robotic TechnologY (PARTY) trial
Introduction Percutaneous coronary intervention (PCI) is performed by interventional cardiologists who, over their career, are exposed to substantial X-ray radiation and also face potential musculoskeletal injuries from the prolonged wearing of heavy protective equipment. Patients are also at risk f...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2024-11-01
|
| Series: | Open Heart |
| Online Access: | https://openheart.bmj.com/content/11/2/e002950.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850219098126942208 |
|---|---|
| author | Rohan Rajaratnam Craig Juergens Sidney T Lo Dominic Y Leung John K French James Xu James Leung Hashim Kachwalla Krishna Kaddapu Tamer Badie Christian Mussap |
| author_facet | Rohan Rajaratnam Craig Juergens Sidney T Lo Dominic Y Leung John K French James Xu James Leung Hashim Kachwalla Krishna Kaddapu Tamer Badie Christian Mussap |
| author_sort | Rohan Rajaratnam |
| collection | DOAJ |
| description | Introduction Percutaneous coronary intervention (PCI) is performed by interventional cardiologists who, over their career, are exposed to substantial X-ray radiation and also face potential musculoskeletal injuries from the prolonged wearing of heavy protective equipment. Patients are also at risk from radiation exposure. Robotic-assisted PCI (R-PCI) allows millimetre control of the coronary guide-catheter, guidewires and intracoronary devices via three joysticks and touchscreens located within in a shielded ‘cockpit’, away from radiation. Initial studies have demonstrated efficacy and safety of R-PCI with significant radiation reductions. However, these studies are non-randomised, registry based or observational data with short clinical follow-up. We aim to perform the first randomised controlled trial investigating R-PCI compared with manual PCI (M-PCI) with longer clinical follow-up.Methods and analysis The Percutaneous coronary intervention using Assisted Robotic TechnologY (PARTY) trial is a single-centre, prospective, randomised, open-label clinical trial comparing R-PCI to M-PCI. Eligible patients between 18 and 85 years undergoing coronary angiography, and are subsequently deemed to require PCI, will be screened. A key exclusion criterion is if the operator determines that the participant or coronary anatomy is unsuitable for R-PCI. Patients will be randomised to R-PCI or M-PCI in a 1:1 fashion. The primary outcome is radiation exposure to the patient, as measured by personal radiation dosimeters. Other procedural, safety and efficacy outcomes will be compared. Patients will be followed up until hospital discharge (or 72 hours, whichever occurs first), and then by telephone at 30 and 365 days.Trial registration number ACTRN12623000480684. |
| format | Article |
| id | doaj-art-9307801ac3c14f6eb6215f89ee20a253 |
| institution | OA Journals |
| issn | 2053-3624 |
| language | English |
| publishDate | 2024-11-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | Open Heart |
| spelling | doaj-art-9307801ac3c14f6eb6215f89ee20a2532025-08-20T02:07:30ZengBMJ Publishing GroupOpen Heart2053-36242024-11-0111210.1136/openhrt-2024-002950Rationale and design of the randomised, controlled Percutaneous coronary intervention using Assisted Robotic TechnologY (PARTY) trialRohan Rajaratnam0Craig Juergens1Sidney T Lo2Dominic Y Leung3John K French4James Xu5James Leung6Hashim Kachwalla7Krishna Kaddapu8Tamer Badie9Christian Mussap10Department of Cardiology, Liverpool Hospital, Liverpool, New South Wales, AustraliaDepartment of Cardiology, Liverpool Hospital, Liverpool, New South Wales, AustraliaCardiology, University of New South Wales, Liverpool Hospital, Liverpool, New South Wales, Australia3 Cardiology, University of New South Wales, Liverpool Hospital, Liverpool, New South Wales, AustraliaCoronary Care Unit, Green Lane Hospital, Auckland, New ZealandSaint Louis University School of Public Health, St Louis, Missouri, USAUniversity of New South Wales, Sydney, New South Wales, AustraliaDepartment of Cardiology, Campbelltown Hospital, Campbelltown, New South Wales, AustraliaDepartment of Cardiology, Campbelltown Hospital, Campbelltown, New South Wales, AustraliaDepartment of Cardiology, Campbelltown Hospital, Campbelltown, New South Wales, AustraliaDepartment of Cardiology, Liverpool Hospital, Liverpool, New South Wales, AustraliaIntroduction Percutaneous coronary intervention (PCI) is performed by interventional cardiologists who, over their career, are exposed to substantial X-ray radiation and also face potential musculoskeletal injuries from the prolonged wearing of heavy protective equipment. Patients are also at risk from radiation exposure. Robotic-assisted PCI (R-PCI) allows millimetre control of the coronary guide-catheter, guidewires and intracoronary devices via three joysticks and touchscreens located within in a shielded ‘cockpit’, away from radiation. Initial studies have demonstrated efficacy and safety of R-PCI with significant radiation reductions. However, these studies are non-randomised, registry based or observational data with short clinical follow-up. We aim to perform the first randomised controlled trial investigating R-PCI compared with manual PCI (M-PCI) with longer clinical follow-up.Methods and analysis The Percutaneous coronary intervention using Assisted Robotic TechnologY (PARTY) trial is a single-centre, prospective, randomised, open-label clinical trial comparing R-PCI to M-PCI. Eligible patients between 18 and 85 years undergoing coronary angiography, and are subsequently deemed to require PCI, will be screened. A key exclusion criterion is if the operator determines that the participant or coronary anatomy is unsuitable for R-PCI. Patients will be randomised to R-PCI or M-PCI in a 1:1 fashion. The primary outcome is radiation exposure to the patient, as measured by personal radiation dosimeters. Other procedural, safety and efficacy outcomes will be compared. Patients will be followed up until hospital discharge (or 72 hours, whichever occurs first), and then by telephone at 30 and 365 days.Trial registration number ACTRN12623000480684.https://openheart.bmj.com/content/11/2/e002950.full |
| spellingShingle | Rohan Rajaratnam Craig Juergens Sidney T Lo Dominic Y Leung John K French James Xu James Leung Hashim Kachwalla Krishna Kaddapu Tamer Badie Christian Mussap Rationale and design of the randomised, controlled Percutaneous coronary intervention using Assisted Robotic TechnologY (PARTY) trial Open Heart |
| title | Rationale and design of the randomised, controlled Percutaneous coronary intervention using Assisted Robotic TechnologY (PARTY) trial |
| title_full | Rationale and design of the randomised, controlled Percutaneous coronary intervention using Assisted Robotic TechnologY (PARTY) trial |
| title_fullStr | Rationale and design of the randomised, controlled Percutaneous coronary intervention using Assisted Robotic TechnologY (PARTY) trial |
| title_full_unstemmed | Rationale and design of the randomised, controlled Percutaneous coronary intervention using Assisted Robotic TechnologY (PARTY) trial |
| title_short | Rationale and design of the randomised, controlled Percutaneous coronary intervention using Assisted Robotic TechnologY (PARTY) trial |
| title_sort | rationale and design of the randomised controlled percutaneous coronary intervention using assisted robotic technology party trial |
| url | https://openheart.bmj.com/content/11/2/e002950.full |
| work_keys_str_mv | AT rohanrajaratnam rationaleanddesignoftherandomisedcontrolledpercutaneouscoronaryinterventionusingassistedrobotictechnologypartytrial AT craigjuergens rationaleanddesignoftherandomisedcontrolledpercutaneouscoronaryinterventionusingassistedrobotictechnologypartytrial AT sidneytlo rationaleanddesignoftherandomisedcontrolledpercutaneouscoronaryinterventionusingassistedrobotictechnologypartytrial AT dominicyleung rationaleanddesignoftherandomisedcontrolledpercutaneouscoronaryinterventionusingassistedrobotictechnologypartytrial AT johnkfrench rationaleanddesignoftherandomisedcontrolledpercutaneouscoronaryinterventionusingassistedrobotictechnologypartytrial AT jamesxu rationaleanddesignoftherandomisedcontrolledpercutaneouscoronaryinterventionusingassistedrobotictechnologypartytrial AT jamesleung rationaleanddesignoftherandomisedcontrolledpercutaneouscoronaryinterventionusingassistedrobotictechnologypartytrial AT hashimkachwalla rationaleanddesignoftherandomisedcontrolledpercutaneouscoronaryinterventionusingassistedrobotictechnologypartytrial AT krishnakaddapu rationaleanddesignoftherandomisedcontrolledpercutaneouscoronaryinterventionusingassistedrobotictechnologypartytrial AT tamerbadie rationaleanddesignoftherandomisedcontrolledpercutaneouscoronaryinterventionusingassistedrobotictechnologypartytrial AT christianmussap rationaleanddesignoftherandomisedcontrolledpercutaneouscoronaryinterventionusingassistedrobotictechnologypartytrial |